Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor

Marta Alberti, Stefano Sainas, Erika Ronchi, Marco L Lolli, Donatella Boschi, Menico RIZZI, DAVIDE MARIA FERRARIS, RICCARDO MIGGIANO

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

: Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB), an ancient disease which causes 1.5 million deaths worldwide. Dihydroorotate dehydrogenase (DHODH) is a key enzyme of the MTB de novo pyrimidine biosynthesis pathway, and it is essential for MTB growth in vitro, hence representing a promising drug target. We present: i) the biochemical characterization of the full-length MTB DHODH, including the analysis of the kinetic parameters, and ii) the previously unreleased crystal structure of the protein that allowed us to rationally screen our in-house chemical library and identify the first selective inhibitor of mycobacterial DHODH. The inhibitor has fluorescence properties, potentially instrumental to in cellulo imaging studies, and exhibits and IC50 value of 43 μM, paving the way to hit-to-lead process.
Lingua originaleInglese
RivistaFEBS Letters
DOI
Stato di pubblicazionePubblicato - 2023

Keywords

  • Mycobacterium tuberculosis
  • Tuberculosis
  • dihydroorotate dehydrogenase
  • drug discovery
  • pyrimidine biosynthesis

Fingerprint

Entra nei temi di ricerca di 'Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor'. Insieme formano una fingerprint unica.

Cita questo